DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Priority
2. The instant application is a national stage entry of PCT/CA2023/050358, filed March 17, 2023 which claims priority to U.S. Provisional Application no. 63/321,375, filed March 18, 2022.
Status of Claims
3. Claims 1-4, 8-13,18-21, 25, 30-31, and 36-38 are pending and under consideration in the instant application.
Claim Objections
4. Claims 37 and 38 are objected to for depending on a rejected base claim.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
5. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention
6. Claims 30-31 and 36 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Park et al. [Park, Hyan, Bong. Sesterterpenoid and Steroid Metabolites from a
Deep-Water Alaska Sponge Inhibit Wnt/-Catenin Signaling in Colon Cancer Cells. Marine Drugs. 2018, 16, 297; doi:10.3390/md16090297 www.mdpi. Pg 1-15].
Park et al. teaches compound 1 which anticipates the instant claims:
PNG
media_image1.png
172
278
media_image1.png
Greyscale
wherein R2 is OC(=O)CH3, R3 is H, R4 is CH=C(CH3)CH2CH=CHC(=CH)CH3.
Conclusion
7. Claims 1-4, 8-13,18-21, and 25 are allowed.
8. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Samantha Shterengarts whose telephone number is (571)270-5316. The examiner can normally be reached on Monday thru Thursday 9-6pm.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mr. Adam Milligan can be reached on 571-270-7674. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free).
If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/SAMANTHA L SHTERENGARTS/Primary Examiner, Art Unit 1623
Prosecution Insights